| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/27/1997 | WO1997007232A1 Antigenic preparations |
| 02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007211A1 Materials and methods for detection and treatment of insulin-dependent diabetes |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007136A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/27/1997 | WO1997007128A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | WO1997007118A1 Enediyne compounds |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006823A1 Monoclonal antibodies for detecting norwalk virus |
| 02/27/1997 | WO1997006822A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006818A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | WO1997006809A1 Compositions and methods for growth promotion |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997004098A3 MODIFIED HUMAN CHORIONIC (β-hCG) PROTEINS AND THEIR MEDICAL USE |
| 02/27/1997 | WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 02/27/1997 | CA2230195A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229269A1 Enediyne compounds |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229140A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 02/27/1997 | CA2228765A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | CA2227795A1 Allergen-xcd32 fusion proteins |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759466A2 Low binding affinity interleukin-12 beta receptors |
| 02/26/1997 | EP0759442A1 Tumor immunotherapy using anti-idiotypic antibodies |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759072A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0759034A1 Peptides for diagnostics and therapeutics |
| 02/26/1997 | EP0759033A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
| 02/26/1997 | EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758902A1 Compositions and treatment for multiple sclerosis |
| 02/26/1997 | EP0758887A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/26/1997 | EP0758843A1 Modified amino acids for drug delivery |
| 02/26/1997 | EP0552267B1 Engineered bacteriophages and vaccines containing them |
| 02/26/1997 | CN1034104C Preparation method for tumor vaccine |
| 02/25/1997 | USRE35465 Method and agents for removing advanced glycosylation endproducts |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606030 Coconjugates of OMPC, HIV related peptides and anionic moieties |
| 02/25/1997 | US5606017 Antitumor agents |
| 02/25/1997 | US5605885 Administeration of prolactin agonist to immunosuppressed animal or human |
| 02/25/1997 | US5605827 Infectious bursal disease virus VP2 fusion protein expressed by baculovirus |
| 02/25/1997 | US5605814 DNA encoding human prostaglandin receptor EP2 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605803 Human sperm diagnostic |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605793 Adding to cleaved random double stranded fragments one or more single stranded or double stranded oligonucleotides, denaturing into single stranded fragments, incubating |
| 02/25/1997 | US5605792 Genetic engineering |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605692 Polypeptide |
| 02/25/1997 | US5605691 Immunologically active proteins from inclusion bodies |
| 02/25/1997 | US5605689 Treatment of HIV-associated immune thrombocytopenic purpura |
| 02/25/1997 | CA2184046A1 Pharmaceutical compositions containing a neutralized virus and use thereof |
| 02/25/1997 | CA1338948C Composition for macrophage activation |
| 02/20/1997 | WO1997006270A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 02/20/1997 | WO1997006263A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006243A1 Method for purifying viruses by chromatography |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997005900A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | WO1997005899A2 Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
| 02/20/1997 | WO1997005889A1 Non-specific vaccination by d-amino-acid containing compounds |
| 02/20/1997 | WO1997005886A1 Compositions for conferring immunogenicity to a peptide |
| 02/20/1997 | WO1997005884A1 Infant formula and infant formula additives |
| 02/20/1997 | WO1997002810A3 Polymeric lamellar substrate particles for drug delivery |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | WO1996036711A3 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
| 02/20/1997 | WO1996027005A3 Recombinant dna molecules that code for polypeptides with antigenic properties of allergens clah8 and clah12 |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2228522A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2225553A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758656A2 Immunoglobulin activated by mixing with a histamine component |
| 02/19/1997 | EP0758397A1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 02/19/1997 | EP0758396A1 Feline immunodeficiency virus vaccine |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758384A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof |
| 02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 02/19/1997 | EP0758375A1 Method to identify immunocompromised patients at high risk for cryptococcosis |
| 02/19/1997 | EP0758226A1 Red blood cell surrogate |
| 02/19/1997 | EP0758196A1 Compositions and methods of treating tumors |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143373A 乙型肝炎疫苗 Hepatitis B Vaccine |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/19/1997 | CN1034054C Preparing method for improved oligosaccharide conjugate vaccines |
| 02/18/1997 | USRE35457 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |